Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Therapeutic Innovation & Regulatory Science
|
June 10, 2020
Real-World Evidence Utilization in Clinical Development Reflected by US Product Labeling: Statistical Review
Yodit Seifu, Margaret Gamalo-Siebers, Friederike M-S Barthel, et al.
The Oncologist
|
February 12, 2020
FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
Donna Przepiorka, Lola Luo, Sriram Subramaniam, et al.
Journal of AOAC International
|
September 14, 2022
Bridging of a Liquid Chromatography-Tandem Mass Spectrometry Method for Oxytetracycline, Chlortetracycline, and Tetracycline in Bovine Kidney with the Official Microbial Growth Inhibition Assay
Lauren Girard, Hui Li, Charles Feng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2021
FDA Approval Summary: Tivozanib for Relapsed or Refractory Renal Cell Carcinoma
Elaine Chang, Chana Weinstock, Lijun Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 23, 2021
FDA Approval Summary: Fam-Trastuzumab Deruxtecan-Nxki for the Treatment of Unresectable or Metastatic HER2-Positive Breast Cancer
Preeti Narayan, Christy L Osgood, Harpreet Singh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 22, 2023
FDA Approval Summary: Mirvetuximab Soravtansine-Gynx for FRα-Positive, Platinum-Resistant Ovarian Cancer
Asma Dilawari, Mirat Shah, Gwynn Ison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2020
FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast Cancer
Jennifer J Gao, Christy L Osgood, Yutao Gong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 27, 2025
FDA Approval Summary: Datopotamab deruxtecan-dlnk for treatment of patients with unresectable or metastatic, HR-positive, HER2-negative breast cancer
Melanie Royce, Mirat Shah, Lijun Zhang, et al.
Journal of Clinical Microbiology
|
February 17, 2017
Multilaboratory Survey To Evaluate Salmonella Prevalence in Diarrheic and Nondiarrheic Dogs and Cats in the United States between 2012 and 2014
Renate Reimschuessel, Michael Grabenstein, Jake Guag, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2020
FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer
Preeti Narayan, Tatiana M Prowell, Jennifer J Gao, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Therapeutic Innovation & Regulatory Science
|
June 10, 2020
Real-World Evidence Utilization in Clinical Development Reflected by US Product Labeling: Statistical Review
Yodit Seifu, Margaret Gamalo-Siebers, Friederike M-S Barthel, et al.
The Oncologist
|
February 12, 2020
FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
Donna Przepiorka, Lola Luo, Sriram Subramaniam, et al.
Journal of AOAC International
|
September 14, 2022
Bridging of a Liquid Chromatography-Tandem Mass Spectrometry Method for Oxytetracycline, Chlortetracycline, and Tetracycline in Bovine Kidney with the Official Microbial Growth Inhibition Assay
Lauren Girard, Hui Li, Charles Feng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2021
FDA Approval Summary: Tivozanib for Relapsed or Refractory Renal Cell Carcinoma
Elaine Chang, Chana Weinstock, Lijun Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 23, 2021
FDA Approval Summary: Fam-Trastuzumab Deruxtecan-Nxki for the Treatment of Unresectable or Metastatic HER2-Positive Breast Cancer
Preeti Narayan, Christy L Osgood, Harpreet Singh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 22, 2023
FDA Approval Summary: Mirvetuximab Soravtansine-Gynx for FRα-Positive, Platinum-Resistant Ovarian Cancer
Asma Dilawari, Mirat Shah, Gwynn Ison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2020
FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast Cancer
Jennifer J Gao, Christy L Osgood, Yutao Gong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 27, 2025
FDA Approval Summary: Datopotamab deruxtecan-dlnk for treatment of patients with unresectable or metastatic, HR-positive, HER2-negative breast cancer
Melanie Royce, Mirat Shah, Lijun Zhang, et al.
Journal of Clinical Microbiology
|
February 17, 2017
Multilaboratory Survey To Evaluate Salmonella Prevalence in Diarrheic and Nondiarrheic Dogs and Cats in the United States between 2012 and 2014
Renate Reimschuessel, Michael Grabenstein, Jake Guag, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2020
FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer
Preeti Narayan, Tatiana M Prowell, Jennifer J Gao, et al.
Page
of 3